4 Pharmaceuticals Stocks to Buy Now

This week, 4 Pharmaceuticals stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

ANI Pharmaceuticals, Inc.’s (ANIP) ratings are looking better this week, moving up to a B from last week’s C. ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of ANIP stock.

This week, Amphastar Pharmaceuticals, Inc.’s (AMPH) ratings are up from a C last week to a B. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of AMPH stock.

Lipocine, Inc. (LPCN) shows solid improvement this week. The company’s rating rises from a C to a B. Lipocine, Inc. is engaged in the development of pharmaceutical products in the areas of men’’s and women’’s health. For more information, get Portfolio Grader’s complete analysis of LPCN stock.

Evoke Pharma, Inc. (EVOK) gets a higher grade this week, advancing from a C last week to a B. The company also gets A’s in earnings revisions and earnings momentum. For more information, get Portfolio Grader’s complete analysis of EVOK stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/05/4-pharmaceuticals-stocks-to-buy-now-4/.

©2021 InvestorPlace Media, LLC